POLYGENIC CONTRIBUTION TO LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND CARDIOVASCULAR RISK IN MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

low Density Lipoprotein Cholesterol Levels Among Patients with Clinical Atherosclerotic Cardiovascular Disease and Heterozygous Familial Hypercholesterolemia Post Statin Therapy

Value in Health ◽

10.1016/j.jval.2016.03.155 ◽

2016 ◽

Vol 19 (3) ◽

pp. A58

Author(s):

BH Johnson ◽

MM Bonafede ◽

N Princic ◽

DJ Harrison ◽

B Boatman ◽

...

Keyword(s):

Cardiovascular Disease ◽

Statin Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Atherosclerotic Cardiovascular Disease ◽

Low Density ◽

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report

Journal of Clinical Apheresis ◽

10.1002/jca.21632 ◽

2018 ◽

Vol 33 (4) ◽

pp. 546-550 ◽

Cited By ~ 3

Author(s):

M. G. Zenti ◽

C. Stefanutti ◽

V. Sanga ◽

A. Altomari ◽

A. Fabris ◽

...

Keyword(s):

Case Report ◽

Combination Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Lipoprotein Apheresis ◽

Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

The Journal of Pediatrics ◽

10.1016/j.jpeds.2005.11.023 ◽

2006 ◽

Vol 148 (4) ◽

pp. 495-500 ◽

Cited By ~ 44

Author(s):

Lily Jakulj ◽

Maud N. Vissers ◽

Jessica Rodenburg ◽

Albert Wiegman ◽

Mieke D. Trip ◽

...

Keyword(s):

Endothelial Function ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Plant Stanols ◽

A DOSE RESPONSE STUDY ON THE EFFECTS OF 3-HYDROXY-3-ME THYLGLUTARIC ACID ON PLASMA AND LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA

Abstracts ◽

10.1016/b978-0-08-023768-8.51213-5 ◽

1978 ◽

pp. 465

Author(s):

P.J. Lupien ◽

S. Moorjani ◽

D. Brun ◽

P. Bielmann

Keyword(s):

Dose Response ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels ◽

Dose Response Study

Effects of Genetic Variants Associated with Familial Hypercholesterolemia on Low-Density Lipoprotein-Cholesterol Levels and Cardiovascular Outcomes in the Million Veteran Program

Circulation Genomic and Precision Medicine ◽

10.1161/circgen.118.002192 ◽

2018 ◽

Vol 11 (12) ◽

Cited By ~ 1

Author(s):

Yan V. Sun ◽

Scott M. Damrauer ◽

Qin Hui ◽

Themistocles L. Assimes ◽

Yuk-Lam Ho ◽

...

Keyword(s):

Genetic Variants ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Cardiovascular Outcomes ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit

Archives of Cardiovascular Diseases Supplements ◽

10.1016/j.acvdsp.2019.09.331 ◽

2020 ◽

Vol 12 (1) ◽

pp. 160

Author(s):

P. Chemaly ◽

O. Nallet ◽

N. Delarche ◽

L. Belle ◽

R. Boulestreau ◽

...

Keyword(s):

Coronary Care Unit ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels ◽

Coronary Care

Efficacy of Evolocumab vs low‐density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01)

Journal of Clinical Apheresis ◽

10.1002/jca.21752 ◽

2019 ◽

Vol 35 (1) ◽

pp. 9-17 ◽

Cited By ~ 1

Author(s):

Esther Torres ◽

Marian Goicoechea ◽

Andrés Hernández ◽

María L. Rodríguez Ferrero ◽

Ana García ◽

...

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

High Cardiovascular Risk

Effects of 3-Hydroxy-3-methylglutaric Acid on Plasma and Low-Density Lipoprotein Cholesterol Levels in Familial Hypercholesterolemia

The Journal of Clinical Pharmacology ◽

10.1002/j.1552-4604.1979.tb02469.x ◽

1979 ◽

Vol 19 (2-3) ◽

pp. 120-126 ◽

Cited By ~ 14

Author(s):

PAUL-J. LUPIEN ◽

SITAL MOORJANI ◽

DANIEL BRUN ◽

PIERRE BIELMANN

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Baseline, delta, and achieved low‐density lipoprotein cholesterol levels and cardiovascular risk in patients on statin therapy: A post‐hoc resampling mediation analysis of treating new targets [TNT] trial

Clinical and Experimental Pharmacology and Physiology ◽

10.1111/1440-1681.13367 ◽

2020 ◽

Author(s):

Myung Han Hyun ◽

Jae Won Jang ◽

Eunmi Lee ◽

Hyonggin An ◽

Hong Seog Seo

Keyword(s):

Cardiovascular Risk ◽

Statin Therapy ◽

Mediation Analysis ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels ◽

Post Hoc

Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2021.06.016 ◽

2021 ◽

Author(s):

Álvaro Aparisi ◽

Carolina Iglesias-Echeverría ◽

Cristina Ybarra-Falcón ◽

Iván Cusácovich ◽

Aitor Uribarri ◽

...

Keyword(s):

Clinical Outcomes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽